TNFSF13B and rheumatoid arthritis: Moreover, BAFF −871 C/C genotype was also associated with a better response of RA patients treated with rituximab, suggesting that a pharmacogenetics pre-evaluation could be useful to improve the efficacy of these biological treatments in RA patients (Table 2).